In Case You Haven't Heard…

“Funny how that works.” Yes. A perceptive insight from ASAM Weekly in last week's issue. “Surveying data can even help keep payers honest…sometimes. An analysis of Medicaid benefits documentation found that less than half of managed care plans (MCP) provide all three FDA‐approved medications for alcohol use disorder (MAUD). But if you spin it differently, over 90% of the same MCPs cover at least one medication for AUD. Funny how that works.” Thanks to ASAM Weekly editor‐in‐chief Nicholas Athanasiou, MD in “Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans.” The three medications, by the way, are acamprosate, disulfiram, and naltrexone. Disulfiram (Antabuse) has fallen out of favor in recent years/decades.

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2025-03-28
DOI
https://doi.org/10.1002/adaw.34473
Primary Topic
Substance Abuse Treatment and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Case You Haven't Heard…

Alcoholism & Drug Abuse Weekly
Substance Abuse Treatment and Outcomes
article

In Case You Haven't Heard…

article en

Abstract

“Funny how that works.” Yes. A perceptive insight from ASAM Weekly in last week's issue. “Surveying data can even help keep payers honest…sometimes. An analysis of Medicaid benefits documentation found that less than half of managed care plans (MCP) provide all three FDA‐approved medications for alcohol use disorder (MAUD). But if you spin it differently, over 90% of the same MCPs cover at least one medication for AUD. Funny how that works.” Thanks to ASAM Weekly editor‐in‐chief Nicholas Athanasiou, MD in “Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans.” The three medications, by the way, are acamprosate, disulfiram, and naltrexone. Disulfiram (Antabuse) has fallen out of favor in recent years/decades.

Alcoholism & Drug Abuse WeeklyVol. 37(13)
Openalex Percentile: Top 91%
Substance Abuse Treatment and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In Case You Haven't Heard… · Alcoholism & Drug Abuse Weekly (2025) | TGRS Research Map | TGRS